Publications

Title

Author

Year

Immunogenicity and Tolerability in Infants of a New Zealand Epidemic Strain Meningococcal B Outer Membrane Vesicle Vaccine.

Wong, SH; Lennon, DR; JACKSON, CM; Stewart, JM; Reid, S; Ypma, E; O'Hallahan, JM; Oster, P; MULHOLLAND, K; Martin, DR;

2009

The Pediatric infectious disease journal, (2009).28 5 10.1097/INF.0b013e318195205e.

A courageous step down the road toward a new tuberculosis vaccine.

DOCKRELL, HM; Zhang, Y;

2009

American journal of respiratory and critical care medicine, (2009).179 8 10.1164/rccm.200901-0144ED.

A vaccine against malaria: a substantial step forward.

Moorthy, V; SMITH, PG; Kieny, M-P;

2009

Lancet, (2009).373 9673 10.1016/S0140-6736(09)60802-3.

Five-year safety and immunogenicity of GlaxoSmithKline's candidate malaria vaccine RTS,S/AS02 following administration to semi-immune adult men living in a malaria-endemic region of The Gambia.

BOJANG, K; MILLIGAN, P; Pinder, M; Doherty, T; Leach, A; Ofori-Anyinam, O; Lievens, M; Kester, K; Schaecher, K; Ballou, WR; Cohen, J;

2009

Human vaccines, (2009).5 4 10.4161/hv.5.4.7050.

RTS,S/AS01E vaccine against malaria.

GOSLING, RD; CHANDRAMOHAN, D;

2009

The New England journal of medicine, (2009).360 12 10.1056/NEJMc090025.

Effect of praziquantel treatment of Schistosoma mansoni during pregnancy on intensity of infection and antibody responses to schistosome antigens: results of a randomised, placebo-controlled trial.

Tweyongyere, R; MAWA, PA; Emojong, NO; MPAIRWE, H; Jones, FM; Duong, T; Dunne, DW; Vennervald, BJ; Katunguka-Rwakishaya, E; ELLIOTT, AM;

2009

BMC infectious diseases, (2009).9 1 10.1186/1471-2334-9-32.

Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy.

Lalor, MK; Ben-Smith, A; GORAK-STOLINSKA, P; Weir, RE; FLOYD, S; BLITZ, R; Mvula, H; Newport, MJ; BRANSON, K; McGrath, N; CRAMPIN, AC; FINE, PE M; DOCKRELL, HM;

2009

The Journal of infectious diseases, (2009).199 6 10.1086/597069.

Clinical trials to estimate the efficacy of preventive interventions against malaria in paediatric populations: a methodological review.

Moorthy, VS; Reed, Z; SMITH, PG;

2009

Malaria journal, (2009).8 1 10.1186/1475-2875-8-23.

Jenner reborn: a new vaccine institute.

Hill, AV S; Shirley, M; GREENWOOD, BM;

2009

Lancet, (2009).373 9662 10.1016/S0140-6736(09)60150-1.

Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa.

Freeman, EE; WHITE, RG; Bakker, R; Orroth, KK; WEISS, HA; Buvé, A; HAYES, RJ; GLYNN, JR;

2009

Vaccine, (2009).27 6 10.1016/j.vaccine.2008.11.074.